financetom
Business
financetom
/
Business
/
Ready Capital Swings to Q4 Loss, Revenue Falls
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Ready Capital Swings to Q4 Loss, Revenue Falls
Mar 3, 2025 5:18 AM

07:56 AM EST, 03/03/2025 (MT Newswires) -- Ready Capital ( RC ) reported a Q4 loss from continuing operations Monday of $1.80 per diluted share, swinging from earnings of $0.12 a year earlier.

No analyst estimates were available for comparison.

Revenue for the quarter ended Dec. 31, expressed as the sum of net interest income and total noninterest income, was $77.1 million, compared with $112.6 million a year earlier.

Three analysts surveyed by FactSet expected $97.4 million.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Swedish court upholds ruling against Tesla in labour dispute
Swedish court upholds ruling against Tesla in labour dispute
Oct 11, 2024
COPENHAGEN (Reuters) - A Swedish district court on Friday upheld a preliminary ruling that Sweden's postal service Postnord does not need to deliver licence plates to Tesla, which are being blocked by the postal workers as part of a wider labour union sympathy strike. The U.S. car maker faces pressure in the Nordic countries from powerful employee unions backing mechanics...
BRIEF-Vecima Acquires Falcon V Systems
BRIEF-Vecima Acquires Falcon V Systems
Oct 11, 2024
Oct 11 (Reuters) - Vecima Networks Inc ( VNWTF ): * VECIMA ACQUIRES FALCON V SYSTEMS, PROVIDER OF INNOVATIVE SOFTWARE ORCHESTRATION PLATFORM FOR CABLE, FIBER, AND MOBILE ACCESS NETWORKS * VECIMA NETWORKS ( VNWTF ): CHARTER COMMUNICATIONS WILL BE INITIAL CUSTOMER, SIGNING MULTI-YEAR DEAL TO DEPLOY BOTH PRINCIPAL CORE & TEST SUITE Source text for Eikon: Further company coverage: ...
CAMP4 Therapeutics Prices $75 Million IPO
CAMP4 Therapeutics Prices $75 Million IPO
Oct 11, 2024
07:33 AM EDT, 10/11/2024 (MT Newswires) -- CAMP4 Therapeutics said late Thursday it priced its initial public offering of about 6.8 million common shares at $11 per share for expected gross proceeds of about $75 million. Underwriters have been granted a 30-day option to buy up to about 1 million additional shares. Shares of the biotechnology company are expected to...
AGBA, Triller Complete All Steps for Merger, Awaiting Final Nasdaq Approval
AGBA, Triller Complete All Steps for Merger, Awaiting Final Nasdaq Approval
Oct 11, 2024
07:44 AM EDT, 10/11/2024 (MT Newswires) -- AGBA (AGBA) and Triller said Friday they have finalized all necessary steps for their upcoming merger, expected to be completed around Oct. 14, pending final Nasdaq approval. As part of the merger, AGBA will undergo a reverse stock split at a 4-to-1 ratio to comply with Nasdaq requirements. The reverse split will be...
Copyright 2023-2026 - www.financetom.com All Rights Reserved